Smart pumps improve medication safety but increase alert burden in neonatal care.
Alert fatigue
Infusion pump alerts
Medication administration errors
Patient safety
Smart infusion pumps
Journal
BMC medical informatics and decision making
ISSN: 1472-6947
Titre abrégé: BMC Med Inform Decis Mak
Pays: England
ID NLM: 101088682
Informations de publication
Date de publication:
07 11 2019
07 11 2019
Historique:
received:
11
08
2019
accepted:
21
10
2019
entrez:
9
11
2019
pubmed:
9
11
2019
medline:
26
5
2020
Statut:
epublish
Résumé
Smart pumps have been widely adopted but there is limited evidence to understand and support their use in pediatric populations. Our objective was to assess whether smart pumps are effective at reducing medication errors in the neonatal population and determine whether they are a source of alert burden and alert fatigue in an intensive care environment. Using smart pump records, over 370,000 infusion starts for continuously infused medications used in neonates and infants hospitalized in a level IV NICU from 2014 to 2016 were evaluated. Attempts to exceed preset soft and hard maximum limits, percent variance from those limits, and pump alert frequency, patterns and salience were evaluated. Smart pumps prevented 160 attempts to exceed the hard maximum limit for doses that were as high as 7-29 times the maximum dose and resulted in the reprogramming or cancellation of 2093 infusions after soft maximum alerts. While the overall alert burden from smart pumps for continuous infusions was not high, alerts clustered around specific patients and medications, and a small portion (17%) of infusions generated the majority of alerts. Soft maximum alerts were often overridden (79%), consistent with low alert salience. Smart pumps have the ability to improve neonatal medication safety when compliance with dose error reducing software is high. Numerous attempts to administer high doses were intercepted by dosing alerts. Clustered alerts may generate a high alert burden and limit safety benefit by desensitizing providers to alerts. Future efforts should address ways to improve alert salience.
Sections du résumé
BACKGROUND
Smart pumps have been widely adopted but there is limited evidence to understand and support their use in pediatric populations. Our objective was to assess whether smart pumps are effective at reducing medication errors in the neonatal population and determine whether they are a source of alert burden and alert fatigue in an intensive care environment.
METHODS
Using smart pump records, over 370,000 infusion starts for continuously infused medications used in neonates and infants hospitalized in a level IV NICU from 2014 to 2016 were evaluated. Attempts to exceed preset soft and hard maximum limits, percent variance from those limits, and pump alert frequency, patterns and salience were evaluated.
RESULTS
Smart pumps prevented 160 attempts to exceed the hard maximum limit for doses that were as high as 7-29 times the maximum dose and resulted in the reprogramming or cancellation of 2093 infusions after soft maximum alerts. While the overall alert burden from smart pumps for continuous infusions was not high, alerts clustered around specific patients and medications, and a small portion (17%) of infusions generated the majority of alerts. Soft maximum alerts were often overridden (79%), consistent with low alert salience.
CONCLUSIONS
Smart pumps have the ability to improve neonatal medication safety when compliance with dose error reducing software is high. Numerous attempts to administer high doses were intercepted by dosing alerts. Clustered alerts may generate a high alert burden and limit safety benefit by desensitizing providers to alerts. Future efforts should address ways to improve alert salience.
Identifiants
pubmed: 31699078
doi: 10.1186/s12911-019-0945-2
pii: 10.1186/s12911-019-0945-2
pmc: PMC6836424
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
213Subventions
Organisme : NLM NIH HHS
ID : R01 LM012230
Pays : United States
Références
Am J Health Syst Pharm. 2015 Jul 1;72(13):1119-37
pubmed: 26092963
Clin Perinatol. 2017 Sep;44(3):713-728
pubmed: 28802348
J Am Med Inform Assoc. 2008 Jul-Aug;15(4):408-23
pubmed: 18436903
Yearb Med Inform. 2016 Nov 10;(1):163-169
pubmed: 27830246
JAMA. 1995 Jul 5;274(1):35-43
pubmed: 7791256
J Am Med Inform Assoc. 2004 Mar-Apr;11(2):104-12
pubmed: 14633936
Int J Med Inform. 2012 May;81(5):344-50
pubmed: 22078107
J Am Med Inform Assoc. 2008 Jul-Aug;15(4):439-48
pubmed: 18436915
J Healthc Qual. 2013 Mar-Apr;35(2):33-40
pubmed: 22103759
Am J Health Syst Pharm. 2013 Apr 15;70(8):680-6
pubmed: 23552046
Arch Dis Child Fetal Neonatal Ed. 2004 Nov;89(6):F472-3
pubmed: 15499131
Am J Health Syst Pharm. 2013 Nov 1;70(21):1897-906
pubmed: 24128965
P T. 2010 Sep;35(9):489-529
pubmed: 20975805
J Am Med Inform Assoc. 2012 Jun;19(e1):e145-8
pubmed: 22534081
JAMA. 2001 Apr 25;285(16):2114-20
pubmed: 11311101
Appl Clin Inform. 2017 May 10;8(2):491-501
pubmed: 28487930
Am J Health Syst Pharm. 2006 Feb 15;63(4):327-45
pubmed: 16452519
Drug Saf. 2014 Dec;37(12):1011-20
pubmed: 25294653
Am J Health Syst Pharm. 2010 Sep 1;67(17):1446-55
pubmed: 20720244
J Am Med Inform Assoc. 2006 Mar-Apr;13(2):138-47
pubmed: 16357358
Drug Saf. 2012 Jul 1;35(7):563-74
pubmed: 22671864
BMC Med Inform Decis Mak. 2017 Apr 10;17(1):36
pubmed: 28395667
BMC Pediatr. 2015 Dec 11;15:206
pubmed: 26654316
Pediatrics. 2013 Jun;131(6):e1948-9
pubmed: 23713102
Appl Clin Inform. 2014 Jan 08;5(1):25-45
pubmed: 24734122
Biomed Instrum Technol. 2015 Fall;Suppl:23-8
pubmed: 26444046
Pediatrics. 2013 Jun;131(6):e1970-3
pubmed: 23713099
Artif Intell Med. 2012 Mar;54(3):155-61
pubmed: 22226048
Arch Dis Child. 2012 Jun;97(6):564-8
pubmed: 22362718
Mil Med. 2014 Aug;179(8 Suppl):4-10
pubmed: 25102542
Am J Health Syst Pharm. 2018 Jun 15;75(12):893-900
pubmed: 29880525